Widget powered by WhatstheScore.com

Author Topic: Scientist Says Trojan Horse Antibody Strategy Shows Promise Against Ebola Virus  (Read 152 times)

0 Members and 1 Guest are viewing this topic.

Offline newspostng

  • Global Moderator
  • Sr. Member
  • *****
  • Posts: 355
    • View Profile

Scientists have found a hidden weak spot shared by all five known types of the deadly Ebola virus and successfully targeted it with two antibodies that blocked its ability to invade human cells.

In early stage laboratory experiments published in the journal Science, the researchers developed a "Trojan horse" strategy that allows engineered antibodies to hitch a ride on Ebola to where the virus is most vulnerable before hitting it.

"The success in co-opting the virus itself to dispatch a lethal weapon ... marks a turning point in development of smart therapeutics against infectious diseases," said M. Javad Aman, a scientist and president at the U.S. biotech firm Integrated BioTherapeutics who worked on the team.

Although years of testing lie ahead before any fully approved treatment might be developed for Ebola patients, Aman said similar strategies could also be devised against several other viral and bacterial pathogens.

No approved treatments

Ebola is an extremely deadly and contagious disease for which there are currently no regulator-approved vaccines or treatments. A vast outbreak of the Zaire strain of the virus, which causes hemorrhagic fever, killed more than 11,000 people and infected around 29,000 in West Africa in 2014-15.

Monoclonal antibodies, which bind to and neutralize specific pathogens and toxins, have emerged as the most promising treatments for Ebola. But a critical problem is that most antibody therapies including the most promising experimental therapy, ZMapp target only one specific Ebola virus.

In this work, the research team found a way around this by targeting a weak spot in the so-called lysosome of the cell to where antibodies could hitch a ride on Ebola and deliver a punch that blocked the virus' exit and ability to replicate.

The strategy could eventually be developed for use in a range of other viruses, the scientists said, including cousins of Ebola such as Marburg, and other viral diseases such as dengue or Lassa.

"It's impossible to predict where the next Ebola virus outbreak will occur or which virus will cause it," said Jon Lai of the Albert Einstein College of Medicine in New York City, who co-led the work. "We hope that further testing in nonhuman primates will establish our antibodies as safe and effective for treating those exposed to any Ebola virus."


Ebola drug "ZMapp" trial begins in Liberia

Started by admin

Replies: 0
Views: 406
Last post February 27, 2015, 11:19:22 PM
by admin
World health Organization announce Ebola as No Longer Extraordinary Health Risk

Started by newspostng

Replies: 0
Views: 140
Last post March 30, 2016, 08:22:11 PM
by newspostng
Ebola: Federal Government of Nigeria bans inter-state movement of corpses

Started by internet police

Replies: 0
Views: 290
Last post August 13, 2014, 08:06:59 AM
by internet police
Nigerian nurse with suspected Ebola, fled quarantine centre in Lagos for Enugu

Started by mastercode

Replies: 0
Views: 267
Last post August 14, 2014, 07:58:45 AM
by mastercode
Nigerians blast US FDA for calling its Ebola trial drug 'Nano Silver a pesticide

Started by internet police

Replies: 0
Views: 213
Last post August 17, 2014, 02:40:59 PM
by internet police